Acumen Pharmaceuticals Inc (NASDAQ: ABOS) on Monday, soared 12.14% from the previous trading day, before settling in for the closing price of $1.73. Within the past 52 weeks, ABOS’s price has moved between $0.86 and $3.36.
Healthcare Sector giant saw their annual sales slid by -54.87% over the last five years. The company achieved an average annual earnings per share of -31.64%. With a float of $46.91 million, this company’s outstanding shares have now reached $60.57 million.
Acumen Pharmaceuticals Inc (ABOS) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Acumen Pharmaceuticals Inc is 22.56%, while institutional ownership is 54.10%. The most recent insider transaction that took place on Jan 23 ’25, was worth 49,633. In this transaction CFO & Chief Business Officer of this company sold 28,902 shares at a rate of $1.72, taking the stock ownership to the 231,744 shares. Before that another transaction happened on Jan 21 ’25, when Company’s CFO & Chief Business Officer sold 4,364 for $1.60, making the entire transaction worth $6,986. This insider now owns 260,646 shares in total.
Acumen Pharmaceuticals Inc (ABOS) Earnings and Forecasts
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.5 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.3) by -0.2. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.57 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -31.64% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.19% during the next five years compared to -54.87% drop over the previous five years of trading.
Acumen Pharmaceuticals Inc (NASDAQ: ABOS) Trading Performance Indicators
Acumen Pharmaceuticals Inc (ABOS) is currently performing well based on its current performance indicators. A quick ratio of 5.97 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.27, a number that is poised to hit -0.60 in the next quarter and is forecasted to reach -1.67 in one year’s time.
Technical Analysis of Acumen Pharmaceuticals Inc (ABOS)
Analysing the last 5-days average volume posted by the [Acumen Pharmaceuticals Inc, ABOS], we can find that recorded value of 0.52 million was better than the volume posted last year of 0.33 million. As of the previous 9 days, the stock’s Stochastic %D was 88.07%.
During the past 100 days, Acumen Pharmaceuticals Inc’s (ABOS) raw stochastic average was set at 98.98%, which indicates a significant increase from 98.63% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1488 in the past 14 days, which was higher than the 0.0986 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4158, while its 200-day Moving Average is $1.3310. Now, the first resistance to watch is $2.0367. This is followed by the second major resistance level at $2.1333. The third major resistance level sits at $2.3167. If the price goes on to break the first support level at $1.7567, it is likely to go to the next support level at $1.5733. Should the price break the second support level, the third support level stands at $1.4767.
Acumen Pharmaceuticals Inc (NASDAQ: ABOS) Key Stats
Market capitalization of the company is 117.51 million based on 60,573K outstanding shares. Right now, sales total 0 K and income totals -102,330 K. The company made 0 K in profit during its latest quarter, and -40,950 K in sales during its previous quarter.
